181 related articles for article (PubMed ID: 8256481)
1. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
Lotterer E; Fleig WE
Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
[No Abstract] [Full Text] [Related]
2. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
4. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic trials in primary biliary cirrhosis.
Sherlock S
QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
[No Abstract] [Full Text] [Related]
6. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].
Siboni AH
Ugeskr Laeger; 2004 Aug; 166(32):2688; author reply 2688. PubMed ID: 15347178
[No Abstract] [Full Text] [Related]
7. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
8. [What is guaranteed in the therapy of primary biliary cirrhosis with bile acids?].
Leuschner U
Internist (Berl); 1990 Nov; 31(11):707-11. PubMed ID: 2289857
[No Abstract] [Full Text] [Related]
9. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
Leuschner U; Fischer H; Hübner K
Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
[No Abstract] [Full Text] [Related]
10. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M
Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
Batts KP; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy.
Zukowski TH; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1998 Jun; 93(6):958-61. PubMed ID: 9647028
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
[TBL] [Abstract][Full Text] [Related]
16. [Ursodeoxycholic acid in primary biliary cirrhosis. 2: Prospective long-term study of 21 patients].
Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
Fortschr Med; 1988 Nov; 106(34):695-8. PubMed ID: 3145247
[No Abstract] [Full Text] [Related]
17. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
[TBL] [Abstract][Full Text] [Related]
18. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
Raedsch R; Stiehl A; Hopf U; Möller B
Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
[No Abstract] [Full Text] [Related]
19. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
[No Abstract] [Full Text] [Related]
20. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
Yan G; Erik C; Gluud C
Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
